ホーム › 転移性癌 › フロリダ州 › Jacksonville
Jacksonville、FLにおける転移性癌の臨床試験
Jacksonvilleとその周辺地域（約30マイル以内）の拠点で、転移性癌に関する28件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
被験者募集中第2相
- Mayo Clinic in Florida, Jacksonville
SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial
被験者募集中第2相
- Mayo Clinic in Florida, Jacksonville
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
被験者募集中第2/3相
- Mayo Clinic - Florida, Jacksonville
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
被験者募集中第3相
- Mayo Clinic Pharmacy, Jacksonville
- Mayo Clinic, Jacksonville
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
被験者募集中第1相
- Mayo Clinic Florida, Jacksonville
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
被験者募集中第2相
- Mayo Clinic, Jacksonville
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
被験者募集中第2/3相
- Mayo Clinic Pharmacy, Jacksonville
- Mayo Clinic, Jacksonville
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
被験者募集中第3相
- Cancer Specialists of North Florida, Jacksonville
- Cancer Specialists of North Florida, Jacksonville
- Cancer Specialists of North Florida, Jacksonville
- 他4件
MTI-301 for the Treatment of Metastatic or Unresectable and Refractory Solid Cancers
被験者募集中第1相
- Mayo Clinic in Florida, Jacksonville
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
被験者募集中第3相
- Baptist MD Anderson Cancer Center, Jacksonville
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
被験者募集中第3相
- Mayo Clinic in Florida, Jacksonville
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
被験者募集中第2相
- Mayo Clinic Florida, Jacksonville
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
被験者募集中第1/2相
- Mayo Clinic Pharmacy, Jacksonville
A Study of KK2269 in Adult Participants With Solid Tumors
被験者募集中第1相
- Mayo Clinic Jacksonville, Jacksonville
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
被験者募集中第3相
- University of Florida - Jacksonville, Jacksonville
Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer
被験者募集中第1相
- Mayo Clinic in Florida, Jacksonville
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
被験者募集中第3相
- Mayo Clinic Florida-Comprehensive Cancer Center, Jacksonville
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
被験者募集中第1相
- Mayo Clinic - Florida, Jacksonville
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
被験者募集中第1/2相
- Mayo Clinic in Florida, Jacksonville
FOG-001 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Mayo Clinic, Jacksonville
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Mayo Clinic (Florida), Jacksonville
- Cancer Specialists of North Florida, Jacksonville
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
被験者募集中第2/3相
- Mayo Clinic Comprehensive Cancer Center, Jacksonville
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
被験者募集中第2/3相
- Mayo Clinic - Jacksonville FL, Jacksonville
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
被験者募集中観察研究
- Mayo Clinic in Florida, Jacksonville
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
被験者募集中第3相
- Mayo Clinic - Jacksonville, Fl, Jacksonville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Jacksonville
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
被験者募集中第1/2相
- Mayo Clinic, Jacksonville
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
被験者募集中第1/2相
- Mayo Clinic in Florida, Jacksonville
他の都市における転移性癌の試験
- Houston, TX104件の研究
- New York City, NY93件の研究
- Nashville, TN70件の研究
- Boston, MA63件の研究
- Los Angeles, CA57件の研究
- St. Louis, MO54件の研究
- Arlington, VA53件の研究
- Philadelphia, PA46件の研究
- Chicago, IL45件の研究
- San Antonio, TX44件の研究
- Washington, DC43件の研究
- Dallas, TX42件の研究
Jacksonvilleにおける他の研究
- 乳がん40件の研究
- 非小細胞肺癌39件の研究
- がん（全種類）29件の研究
- 大腸癌27件の研究
- 前立腺がん26件の研究
- 肥満症25件の研究
- 心不全21件の研究
- 膵臓がん20件の研究
- 過体重19件の研究
- 多発性骨髄腫18件の研究
- 肺がん17件の研究
- 悪性黒色腫16件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。